ReviewPharmaceutics2026

From Concept to Clinic: Vepdegestrant (ARV 471) Becomes the First Approved PROTAC Drug.

Miklós Bege et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.